Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Latest news
Another Alzheimer’s Trial Cancelled: Lilly, Roche Drugs Fail to Reduce Beta-Amyloid
Researchers Pinpoint Genetic Mutations That May Protect Against Alzheimer’s
Fighting Proteins with Proteins: CPPs May Counter Amyloid Buildup
Teepa Snow on Living Well With Alzheimer’s, for Patients and Caregivers
FDA Approves Insomnia Drug, Suvorexant, for Alzheimer’s Patients
Alexa, Siri May One Day Detect Dementia
The Link Between High Blood Pressure and Dementia
How Flavonols, Found in Fruit and Tea, Can Stave Off Alzheimer’s
Artificial Intelligence Analyzes Blood Samples, Accurately Predicts Alzheimer’s
Researchers Explore Lithium as Treatment for Alzheimer’s Disease
FDA Gives Biogen Green Light to Relaunch Aducanumab Study on Trial Participants
Bigger Risk for Smaller Brains: Concussions in Youth Football
Living Close to Major Roads or Highways Linked to Dementia
Windows to the Brain: Retinal Testing for Alzheimer’s
Researchers Pinpoint Protein, ‘Aggregatin,’ as New Biomarker for Alzheimer’s
Previous
104
105
106
Next
Page load link
Go to Top